BO CHI

Dr. BO CHI

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2017 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
RWRui Wang
Rui Wang
JLJingzhe Li
Jingzhe Li
WCWei Chen
Wei Chen
TXTingting Xu
Tingting Xu
SYShifeng Yun
Shifeng Yun
HXHong Xu
Hong Xu

1 June 2021 in Acta Biomaterialia
Verified
Journal Article
Closed access
RYRong Yang
Rong Yang
XLXin Liu
Xin Liu
YRYanhan Ren
Yanhan Ren
WXWenliang Xue
Wenliang Xue
SLShuai Liu
Shuai Liu
BCBO CHI
BO CHI

29 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JHJinjian Huang
Jinjian Huang
RYRong Yang
Rong Yang
JJJiao Jiao
Jiao Jiao
ZLZe Li
Ze Li
PWPenghui Wang
Penghui Wang
RJRen Jian'an
Ren Jian'an
High glucose-induced vascular endothelial injury is a major pathological factor involved in non-healing diabetic wounds. To interrupt this pathological process, we design an all-peptide printable hydrogel platform based on highly efficient and precise one-step click chemistry of thiolated γ-polyglutamic acid, glycidyl methacrylate-conjugated γ-polyglutamic acid, and thiolated arginine-glycine-aspartate sequences. Vascular endothelial growth factor 165-overexpressed human umbilical vein endothelial cells are printed using this platform, hence fabricating a living material with high cell viability and precise cell spatial distribution control. This cell-laden hydrogel platform accelerates the diabetic wound healing of rats based on the unabated vascular endothelial growth factor 165 release, which promotes angiogenesis and alleviates damages on vascular endothelial mitochondria, thereby reducing tissue hypoxia, downregulating inflammation, and facilitating extracellular matrix remodeling. Together, this study offers a promising strategy for fabricating tissue-friendly, high-efficient, and accurate 3D printed all-peptide hydrogel platform for cell delivery and self-renewable growth factor therapy.

1 January 2018 in Carbohydrate Polymers
Verified
Journal Article
Closed access
XMXuebin Ma
Xuebin Ma
TXTingting Xu
Tingting Xu
WCWei Chen
Wei Chen
HQHongye Qin
Hongye Qin
BCBO CHI
BO CHI
ZYZhiwen Ye
Zhiwen Ye

1 September 2021 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
XWXiaoxue Wang
Xiaoxue Wang
JQJingjie Qi
Jingjie Qi
WZWenjie Zhang
Wenjie Zhang
YPYajie Pu
Yajie Pu
RYRong Yang
Rong Yang
BCBO CHI
BO CHI

19 June 2017 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
WCWei Chen
Wei Chen
RWrui wang
rui wang
TXTingting Xu
Tingting Xu
XMXuebin Ma
Xuebin Ma
ZYZhong Yao
Zhong Yao
HXHong Xu
Hong Xu
Injectable hydrogels are promising candidates for adhesives because of their ease of administration, minimal invasion, and biocompatibility. While developing surgical adhesives with strong wet tissue adhesion, controlled degradability and mechanical properties, and excellent biocompatibility have still been a significant challenge. Herein, inspired from nature, we report a novel mussel-inspired tissue-adhesive hydrogel composed of poly(γ-glutamic acid) and dopamine (γ-PGA–DA) that can bond tissues well and stop bleeding in a wet environment by improving its tissue adhesiveness via a horseradish peroxidase-mediated reaction. The hydrogel exhibited 10–12 fold stronger wet tissue adhesion strength (58.2 kPa) over the clinically used fibrin glue and more effective hemostatic ability following liver impalement in animal models (41.2% reduction in the average amount of bleeding compared with fibrin glue). In addition, the hydrogels demonstrated controlled gelation time, swelling ratio, microscopic morphology, biodegradability and tissue-like elastomeric mechanical properties, and exhibited excellent cyto/tissue-compatibility. The overall results suggest that the γ-PGA–DA hydrogels can be considerably applied as promising wet-resistant adhesives and hemostatic materials.